- Report
- February 2025
- 150 Pages
Global
From €3437EUR$3,850USD£3,000GBP
€4330EUR$4,850USD£3,779GBP
- Report
- June 2025
- 400 Pages
Global
From €4418EUR$4,949USD£3,857GBP
- Report
- April 2025
- 235 Pages
Global
From €4017EUR$4,500USD£3,507GBP
- Report
- October 2024
- 200 Pages
United States
From €2223EUR$2,490USD£1,940GBP
- Report
- June 2025
- 89 Pages
North America
From €3080EUR$3,450USD£2,688GBP
- Report
- January 2023
- 190 Pages
United Kingdom
From €2223EUR$2,490USD£1,940GBP
- Report
- October 2024
- 200 Pages
France
From €2223EUR$2,490USD£1,940GBP
- Report
- March 2023
- 190 Pages
Germany
From €2223EUR$2,490USD£1,940GBP
- Report
- May 2025
- 70 Pages
Canada
From €3125EUR$3,500USD£2,727GBP
- Report
- December 2024
- 82 Pages
Indonesia
From €3125EUR$3,500USD£2,727GBP
- Report
- November 2024
- 82 Pages
Vietnam
From €3125EUR$3,500USD£2,727GBP
- Report
- August 2024
- 80 Pages
Japan
From €3125EUR$3,500USD£2,727GBP
- Report
- May 2024
- 183 Pages
Global
From €4017EUR$4,500USD£3,507GBP
- Report
- July 2024
- 90 Pages
China
From €4241EUR$4,750USD£3,701GBP
- Report
- February 2024
- 70 Pages
United States
From €4241EUR$4,750USD£3,701GBP
- Report
- February 2024
- 90 Pages
North America
From €4241EUR$4,750USD£3,701GBP
- Report
- February 2024
- 80 Pages
France
From €4241EUR$4,750USD£3,701GBP
- Report
- February 2024
- 120 Pages
Spain
From €4241EUR$4,750USD£3,701GBP
- Report
- February 2024
- 70 Pages
Thailand
From €4241EUR$4,750USD£3,701GBP
- Report
- February 2024
- 70 Pages
Indonesia
From €4241EUR$4,750USD£3,701GBP

The Automated Insulin Delivery (AID) market is a subset of the larger diabetes devices market. AID systems are designed to help people with diabetes manage their condition by automatically delivering insulin to the body. These systems are typically composed of an insulin pump, a continuous glucose monitor (CGM), and a control algorithm. The CGM measures glucose levels in the body and sends the data to the control algorithm, which then calculates the amount of insulin needed and sends a signal to the insulin pump to deliver the appropriate dose.
AID systems are designed to provide more accurate and consistent insulin delivery than traditional methods, and can help reduce the risk of hypoglycemia and other diabetes-related complications. They are also designed to be user-friendly and provide users with more control over their diabetes management.
Some companies in the AID market include Medtronic, Insulet, Tandem Diabetes Care, Bigfoot Biomedical, and Senseonics. Show Less Read more